Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE20.8700
- TODAY'S CHANGE (%)0.1300 (0.6268%)
- Bid / Lots20.9000/ 7
- Ask / Lots21.0400/ 2
- Open / Previous Close20.8300 / 20.7400
- Day Range
- 52 Week Range
- Volume3,926,432
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 5068 | 20.64 |
| 09:36 ET | 1450 | 20.815 |
| 09:38 ET | 200 | 20.8575 |
| 09:39 ET | 601 | 20.76 |
| 09:41 ET | 710 | 20.64 |
| 09:43 ET | 700 | 20.73 |
| 09:45 ET | 775 | 20.665 |
| 09:48 ET | 400 | 20.66 |
| 09:52 ET | 600 | 20.53 |
| 09:54 ET | 11272 | 20.215 |
| 09:56 ET | 4127 | 20.29 |
| 09:57 ET | 5400 | 20.38 |
| 09:59 ET | 10603 | 20.1211 |
| 10:01 ET | 2284 | 20.28 |
| 10:03 ET | 4972 | 20.11 |
| 10:06 ET | 22957 | 20.2 |
| 10:08 ET | 6117 | 20.16 |
| 10:10 ET | 4767 | 20.12 |
| 10:12 ET | 2758 | 20.215 |
| 10:14 ET | 400 | 20.335 |
| 10:15 ET | 676 | 20.38 |
| 10:17 ET | 7720 | 20.32 |
| 10:19 ET | 1827 | 20.44 |
| 10:21 ET | 1500 | 20.535 |
| 10:24 ET | 11282 | 20.45 |
| 10:26 ET | 1806 | 20.4 |
| 10:28 ET | 800 | 20.32 |
| 10:30 ET | 2943 | 20.12 |
| 10:32 ET | 3684 | 20.235 |
| 10:33 ET | 1209 | 20.06 |
| 10:35 ET | 20168 | 19.99 |
| 10:37 ET | 7002 | 20.06 |
| 10:39 ET | 3320 | 20.06 |
| 10:42 ET | 800 | 20.08 |
| 10:44 ET | 445 | 20.11 |
| 10:46 ET | 1000 | 20.05 |
| 10:48 ET | 2808 | 20.26 |
| 10:50 ET | 1600 | 20.39 |
| 10:51 ET | 3398 | 20.535 |
| 10:53 ET | 1320 | 20.45 |
| 10:55 ET | 1300 | 20.39 |
| 10:57 ET | 400 | 20.41 |
| 11:00 ET | 700 | 20.475 |
| 11:02 ET | 2344 | 20.46 |
| 11:06 ET | 100 | 20.36 |
| 11:08 ET | 1700 | 20.46 |
| 11:09 ET | 1900 | 20.43 |
| 11:11 ET | 2500 | 20.3699 |
| 11:13 ET | 1500 | 20.28 |
| 11:15 ET | 1227 | 20.3 |
| 11:18 ET | 600 | 20.37 |
| 11:20 ET | 500 | 20.405 |
| 11:22 ET | 1964 | 20.41 |
| 11:24 ET | 1608 | 20.47 |
| 11:26 ET | 500 | 20.48 |
| 11:27 ET | 2339 | 20.435 |
| 11:29 ET | 1530 | 20.45 |
| 11:31 ET | 600 | 20.4 |
| 11:33 ET | 1700 | 20.33 |
| 11:36 ET | 900 | 20.34 |
| 11:38 ET | 1200 | 20.39 |
| 11:40 ET | 500 | 20.38 |
| 11:42 ET | 657 | 20.44 |
| 11:44 ET | 1000 | 20.37 |
| 11:45 ET | 700 | 20.37 |
| 11:47 ET | 352 | 20.42 |
| 11:49 ET | 1856 | 20.37 |
| 11:51 ET | 200 | 20.44 |
| 11:54 ET | 300 | 20.48 |
| 11:56 ET | 625 | 20.59 |
| 11:58 ET | 400 | 20.64 |
| 12:00 ET | 1245 | 20.64 |
| 12:02 ET | 762 | 20.63 |
| 12:03 ET | 3400 | 20.7559 |
| 12:05 ET | 405 | 20.705 |
| 12:07 ET | 200 | 20.68 |
| 12:09 ET | 265 | 20.67 |
| 12:12 ET | 1400 | 20.58 |
| 12:14 ET | 200 | 20.63 |
| 12:16 ET | 500 | 20.51 |
| 12:18 ET | 762 | 20.35 |
| 12:20 ET | 1100 | 20.36 |
| 12:23 ET | 600 | 20.33 |
| 12:25 ET | 300 | 20.44 |
| 12:27 ET | 900 | 20.505 |
| 12:30 ET | 100 | 20.505 |
| 12:32 ET | 635 | 20.48 |
| 12:34 ET | 703 | 20.43 |
| 12:36 ET | 400 | 20.35 |
| 12:38 ET | 1662 | 20.43 |
| 12:39 ET | 200 | 20.42 |
| 12:41 ET | 1000 | 20.4 |
| 12:43 ET | 300 | 20.41 |
| 12:45 ET | 600 | 20.43 |
| 12:48 ET | 521 | 20.48 |
| 12:50 ET | 300 | 20.45 |
| 12:52 ET | 500 | 20.485 |
| 12:56 ET | 400 | 20.53 |
| 12:57 ET | 400 | 20.52 |
| 12:59 ET | 869 | 20.54 |
| 01:01 ET | 227 | 20.53 |
| 01:03 ET | 1500 | 20.52 |
| 01:06 ET | 1658 | 20.44 |
| 01:08 ET | 400 | 20.51 |
| 01:10 ET | 400 | 20.47 |
| 01:12 ET | 700 | 20.575 |
| 01:14 ET | 200 | 20.57 |
| 01:15 ET | 537 | 20.64 |
| 01:17 ET | 500 | 20.6 |
| 01:19 ET | 1100 | 20.6 |
| 01:21 ET | 600 | 20.54 |
| 01:24 ET | 1100 | 20.52 |
| 01:26 ET | 853 | 20.51 |
| 01:28 ET | 700 | 20.51 |
| 01:30 ET | 621 | 20.44 |
| 01:32 ET | 300 | 20.41 |
| 01:33 ET | 684 | 20.33 |
| 01:35 ET | 927 | 20.25 |
| 01:37 ET | 1493 | 20.28 |
| 01:39 ET | 1173 | 20.26 |
| 01:44 ET | 1890 | 20.38 |
| 01:46 ET | 231 | 20.44 |
| 01:48 ET | 1571 | 20.39 |
| 01:50 ET | 600 | 20.38 |
| 01:51 ET | 2547 | 20.52 |
| 01:53 ET | 2937 | 20.47 |
| 01:55 ET | 700 | 20.42 |
| 01:57 ET | 1100 | 20.44 |
| 02:00 ET | 296 | 20.43 |
| 02:02 ET | 1014 | 20.46 |
| 02:04 ET | 800 | 20.42 |
| 02:06 ET | 1100 | 20.475 |
| 02:08 ET | 400 | 20.45 |
| 02:09 ET | 1100 | 20.46 |
| 02:11 ET | 947 | 20.55 |
| 02:13 ET | 400 | 20.605 |
| 02:15 ET | 3449 | 20.72 |
| 02:18 ET | 1579 | 20.58 |
| 02:20 ET | 200 | 20.61 |
| 02:22 ET | 600 | 20.64 |
| 02:24 ET | 2399 | 20.66 |
| 02:27 ET | 1300 | 20.65 |
| 02:29 ET | 600 | 20.61 |
| 02:31 ET | 519 | 20.58 |
| 02:33 ET | 100 | 20.56 |
| 02:36 ET | 890 | 20.56 |
| 02:38 ET | 200 | 20.56 |
| 02:40 ET | 300 | 20.55 |
| 02:42 ET | 1161 | 20.59 |
| 02:45 ET | 700 | 20.58 |
| 02:47 ET | 546 | 20.55 |
| 02:49 ET | 2004 | 20.56 |
| 02:51 ET | 500 | 20.43 |
| 02:54 ET | 500 | 20.46 |
| 02:56 ET | 300 | 20.48 |
| 02:58 ET | 200 | 20.47 |
| 03:00 ET | 700 | 20.51 |
| 03:02 ET | 1968 | 20.56 |
| 03:03 ET | 1750 | 20.63 |
| 03:05 ET | 400 | 20.61 |
| 03:07 ET | 1784 | 20.67 |
| 03:09 ET | 2963 | 20.59 |
| 03:12 ET | 1400 | 20.64 |
| 03:14 ET | 400 | 20.67 |
| 03:16 ET | 1252 | 20.7 |
| 03:18 ET | 2635 | 20.575 |
| 03:20 ET | 827 | 20.595 |
| 03:21 ET | 4172 | 20.58 |
| 03:23 ET | 2000 | 20.57 |
| 03:25 ET | 2591 | 20.55 |
| 03:27 ET | 3818 | 20.6 |
| 03:30 ET | 3958 | 20.57 |
| 03:32 ET | 3849 | 20.525 |
| 03:34 ET | 2827 | 20.52 |
| 03:36 ET | 4200 | 20.56 |
| 03:38 ET | 6052 | 20.58 |
| 03:39 ET | 1902 | 20.58 |
| 03:41 ET | 1722 | 20.585 |
| 03:43 ET | 4400 | 20.49 |
| 03:45 ET | 3990 | 20.5 |
| 03:48 ET | 3600 | 20.52 |
| 03:50 ET | 5081 | 20.48 |
| 03:52 ET | 38740 | 20.81 |
| 03:54 ET | 35804 | 20.73 |
| 03:56 ET | 2228 | 20.83 |
| 03:57 ET | 9491 | 20.82 |
| 03:59 ET | 30861 | 20.87 |
Jun 27, 2024
DJ Nurix Therapeutics Is Maintained at Outperform by RBC Capital, from 10:40AM ET on Thursday Jun 27, 2024 by Dow Jones
10:40AM ET on Thursday Jun 27, 2024 by Dow Jones
Jun 18, 2024
DJ Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:20AM ET on Tuesday Jun 18, 2024 by Dow Jones
6:20AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 17, 2024
DJ Nurix Therapeutics Is Maintained at Overweight by JP Morgan, from 10:19AM ET on Monday Jun 17, 2024 by Dow Jones
10:19AM ET on Monday Jun 17, 2024 by Dow JonesDJ Nurix Therapeutics Shares Rise on Positive Leukemia Drug Results, from 6:23AM ET on Monday Jun 17, 2024 by Dow Jones
6:23AM ET on Monday Jun 17, 2024 by Dow JonesDJ Nurix Therapeutics Price Target Maintained With a $31.00/Share by Needham, from 5:59AM ET on Monday Jun 17, 2024 by Dow Jones
5:59AM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.2B | -7.9x | --- |
Vir Biotechnology Inc | 1.2B | -2.2x | --- |
Immatics NV | 1.2B | -11.1x | --- |
Prothena Corporation PLC | 1.1B | -6.3x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -3.2x | --- |
Silence Therapeutics PLC | 886.5M | -16.7x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $80.9M |
Shares Outstanding | 59.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $-2.65 |
Book Value | $4.12 |
P/E Ratio | -7.9x |
Price/Sales (TTM) | 15.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -194.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
